Study Preview
Study Title and Description
Comparison of transobturator tape (TOT) vs Burch method in treatment of stress urinary incontinence.
Key Questions Addressed
1 | Sling vs Comparator RCT outcomes (excluding AEs) | |
2 | Sling Adverse Events |
Primary Publication Information
Title | Comparison of transobturator tape (TOT) vs Burch method in treatment of stress urinary incontinence. |
Author | Bandarian M., Ghanbari Z., Asgari A. |
Country | Department of Obstetrics and Gynecology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran. |
Year | 2011 |
Numbers |
Pubmed ID: 21823854 1485 (internal) |
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Sling vs Comparator RCT outcomes (excluding AEs)
Arms
Number | Title | Description | Comments |
---|---|---|---|
1 | Burch | ||
2 | TOT | type unclear |
Question... Follow Up | Answer | Follow-up Answer | |
---|---|---|---|
Trial Name | n/a | ||
Country | Iran | ||
Outcome Categories Reported | OR outcomes/complications (not "AEs") | ||
Other (we expect this to rarely or never be chosen) ... | "Cure" - unclear if subjective or objective; satisfaction | ||
Population (reason for surgery etc.) | Symptomatic SUI | ||
Urodynamic SUI | |||
RCT Comparison Category | Sling vs. Burch | ||
Multicenter | No | ||
Institution Type | Unclear/Not reported | ||
Number of surgeons performing procedures | 1 | ||
Surgeons' Training | Not reported | ||
Residents or fellows performing surgery? | No | ||
Study Quality (overall) | C (poor) | ||
Overall Study Notes | No power analysis; no standardized measures used. Unclear what urodynamic data were collected. Unclear if "cure" was subjective or objective or both. "Simple" randomization scheme used. Single surgeon. Follow-up done by another surgeon. Complication rate for Burch about twice as high as TOT but apparently statistically similar. | ||
Study Sponsor/Funding ... | Other ... | report no conflicts of interest |
Baseline Characteristics
Question | Burch | TOT | Transobturator synthetic | Burch | Total | Comments | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | Answer | Follow-up | ||
No. Randomized | 31 | 31 | 62 | ||||||||
Mean Age | 47 | 49 | |||||||||
Post-Op Follow-Up Interval (Maximum) | 28 mos | 22 mos |
Results & Comparisons
Results Data
Outcome: Overall complication rate Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
Enter a numeric value or title (required) years |
N Enrolled | 31 | 31 | 0.199 | |||
Percentage | 25.8 | 12.9 |
Outcome: Postop urinary retention Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | TOT vs. Burch |
1 weeks |
N Enrolled | 31 | 31 | 0.3 | |||
Percentage | 9.7 | 3.2 |
Outcome: Bladder/urethral injury Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 days |
N Enrolled | 31 | 31 | ns | |||
Percentage | 0 | 0 |
Outcome: Cure Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 unclear |
N Enrolled | 31 | 31 | ns | |||
Percentage | 74.2 | 90.3 |
Outcome: Improvement Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 unclear |
N Enrolled | 31 | 31 | ns | |||
Percentage | 19.4 | 6.7 |
Outcome: Failure Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 unclear |
N Enrolled | 31 | 31 | ns | |||
Percentage | 6.5 | 0 |
Outcome: "very satisfied" Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 unclear |
N Enrolled | 31 | 31 | ns | |||
Percentage | 74.2 | 90.3 |
Outcome: EBL >300cc Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 days |
N Enrolled | 31 | 31 | ns | |||
Percentage | 3.2 | 3.2 |
Outcome: Duration of procedure Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
Enter a numeric value or title (required) years |
N Analyzed | 31 | 31 | 62 | |||
Mean | 45 | 20 | <0.001 | ||||
Standard Deviation | |||||||
Range | 40-55 | 15-25 |
Outcome: Length of hospital stay Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
Enter a numeric value or title (required) years |
N Analyzed | 31 | 31 | 62 | |||
Mean | 8.23 | 2.06 | 0.001 | ||||
Standard Deviation | 3.98 | 1.03 |
Extraction Form: Sling Adverse Events
Arms
Number | Title | Description | Comments |
---|---|---|---|
1 | Transobturator synthetic | ||
2 | Burch |
Question... Follow Up | Answer | Follow-up Answer | |
---|---|---|---|
Study Type | RCT | ||
Study Country | Iran | ||
Sling Category | Obturator synthetic | ||
Other ... | Burch | ||
Multicenter? | No | ||
Adverse Event Ascertainment | Unclear/Not reported | ||
Was the Clavien-Dindo Classification of Surgical Complications system used? | No / Not reported | ||
Was a data safety monitoring board used? | No / Not reported | ||
Comments (overall study) | Poor quality study. See RCT form. |
Results & Comparisons
Results Data
Outcome: Overall complication rate Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
Enter a numeric value or title (required) years |
N Enrolled | 31 | 31 | 0.199 | |||
Percentage | 25.8 | 12.9 |
Outcome: Postop urinary retention Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | TOT vs. Burch |
1 weeks |
N Enrolled | 31 | 31 | 0.3 | |||
Percentage | 9.7 | 3.2 |
Outcome: Bladder/urethral injury Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 days |
N Enrolled | 31 | 31 | ns | |||
Percentage | 0 | 0 |
Outcome: Cure Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 unclear |
N Enrolled | 31 | 31 | ns | |||
Percentage | 74.2 | 90.3 |
Outcome: Improvement Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 unclear |
N Enrolled | 31 | 31 | ns | |||
Percentage | 19.4 | 6.7 |
Outcome: Failure Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 unclear |
N Enrolled | 31 | 31 | ns | |||
Percentage | 6.5 | 0 |
Outcome: "very satisfied" Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 unclear |
N Enrolled | 31 | 31 | ns | |||
Percentage | 74.2 | 90.3 |
Outcome: EBL >300cc Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
1 days |
N Enrolled | 31 | 31 | ns | |||
Percentage | 3.2 | 3.2 |
Outcome: Duration of procedure Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
Enter a numeric value or title (required) years |
N Analyzed | 31 | 31 | 62 | |||
Mean | 45 | 20 | <0.001 | ||||
Standard Deviation | |||||||
Range | 40-55 | 15-25 |
Outcome: Length of hospital stay Population: All Participants | Between-Arm Comparisons | ||||||
---|---|---|---|---|---|---|---|
Time Point | Measure | Burch | TOT | Transobturator synthetic | Burch | Comparison Measure | Burch vs. TOT |
Enter a numeric value or title (required) years |
N Analyzed | 31 | 31 | 62 | |||
Mean | 8.23 | 2.06 | 0.001 | ||||
Standard Deviation | 3.98 | 1.03 |
Adverse Events
Arm or Total | Title | Description | Follow-up time | In-hospital or After discharge | Is event serious? | Reported definition of serious event | Number affected | Number at risk (analyzed) | Difference between 2 slings (eg, OR/RR or %, with 95% CI) | Reported P value between slings | Comments |
---|---|---|---|---|---|---|---|---|---|---|---|
Transobturator synthetic | Mesh erosion/extrusion/exposure/granulation tissue | mentioned in discussion that one person in TOT group had erosion - treated with antibiotics | 22 mos | after | no | not defined | 1 | 31 | not given | not given | |
Burch | 28 mos | unstated | 31 | ||||||||
Total | |||||||||||
Transobturator synthetic | Organ injury in OR (urethra, bladder, bowel) | 22 mos | in hospital | no | undefined | 0 | 31 | ns | |||
Burch | 28 mos | in hospital | no | undefined | 0 | 31 | ns | ||||
Total | |||||||||||
Transobturator synthetic | Infection, UTI | 22 mos | after | no | undefined | 0 | 31 | ns | |||
Burch | 28 mos | after | no | undefined | 0 | 31 | ns | ||||
Total | |||||||||||
Transobturator synthetic | DVT | 22 mos | unclear | yes | undefined | 0 | 31 | 0.32 | |||
Burch | 28 mos | unclear | yes | undefined | 3.2 | 31 | 0.32 | ||||
Total | |||||||||||
Transobturator synthetic | Infection, surgical site/wound | 22 mos | unclear | no | undefined | 0 | 31 | 0.07 | |||
Burch | 28 mos | unclear | no | undefined | 9.7 | 31 | 0.07 | ||||
Total |